Concepedia

Publication | Open Access

Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

DOIFull Paper Access

503

Citations

25

References

2017

Year

Sara A. Hurvitz, Miguel Martín, W. Fraser Symmans, Kyung Hae Jung, Chiun‐Sheng Huang, Alastair M. Thompson, Nadia Harbeck, Vicente Valero, Daniil Stroyakovskiy, Hans Wildiers,
The Lancet Oncology

Abstract

F Hoffmann-La Roche and Genentech.

References

YearCitations

Page 1